Sponsored By:

4 Pharmaceutical Stocks to Buy Now

JNJ, BMY, WPI, RPRX improve in weekly rankings

   

Four pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an “A” (“strong buy”) or “B” overall (“buy”).

This week, Johnson & Johnson (JNJ) is making solid headway. The company’s rating improves to an A (“strong buy”) from last week’s B (“buy”) rating. Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. In Portfolio Grader’s specific subcategories of Earnings Growth, Earnings Momentum and Equity, JNJ also gets A’s. At present, the stock has a dividend yield of 2.6%. For more information, get Portfolio Grader’s complete analysis of JNJ stock.

Bristol-Myers Squibb Company (BMY) is making progress this week as its rating of C (“hold”) from last week increases to a B (“buy”) rating this week. Bristol-Myers Squibb is a global company that develops, produces and sells pharmaceutical products. For more information, get Portfolio Grader’s complete analysis of BMY stock.

Watson Pharmaceuticals (WPI) is seeing ratings go up from a B last week to an A this week. Watson develops, manufactures, markets, sells and distributes pharmaceutical products. For more information, get Portfolio Grader’s complete analysis of WPI stock.

Repros Therapeutics (RPRX) earns an A this week, jumping up from last week’s grade of B. Repros Therapeutics is a development stage biopharmaceutical company focusing on the development of oral small molecule drugs for major unmet medical needs. The stock price has risen 17.5% over the past month, better than the 1.3% decrease the Nasdaq has seen over the same period of time. For more information, get Portfolio Grader’s complete analysis of RPRX stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, http://investorplace.com/2013/12/4-pharmaceutical-stocks-to-buy-now-jnj-bmy-wpi-31/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.